Nicole A. Cipriani, MD, offers guidance for community oncologists regarding the role of BRAF p.V600E testing in patients with papillary thyroid carcinoma.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

A woman who was diagnosed with thyroid cancer at the age of 20 in 2022 was initially brushed off by doctors with her symptoms ...

Country star Paul Cauthen has shared shares a powerful image and message with his fans months after revealing his cancer ...

Paul Cauthen announced he had cancer back in April and the 40-year-old country music star has pretty much kept it moving since. He has been back out on the road performing for a while now, and he has ...

Objective The aim of this study was to investigate the incidence and risk factors for lateral lymph node metastasis (LLNM) in patients with papillary thyroid carcinoma (PTC). Subjects and methods 356 ...

Objectives The presence of thyroglobulin (Tg) in needle washouts of fine needle aspiration biopsy (Tg-FNAB) in neck lymph nodes (LNs) suspected of metastasis has become a cornerstone in the follow-up ...

Thyroid cancer rises rapidly recent years, especially in Asia (4). Papillary carcinoma (PTC) is the most common type of thyroid cancer, accounting for about 84% (5) of all thyroid cancer. The routine ...

Differentiated thyroid carcinoma (DTC) is typically indolent, and some patients may be managed conservatively without ...

The authors present a histologic and immunohistochemical study of a case of primary thymic adenocarcinoma, an exceedingly rare cancer for which there is little genetic data.

Conclusion This primary adenocarcinoma of the thymus with intestinal differentiation shows homozygous deletion of part of the HLA - locus in chromosomal region 6p21.32 confirmed by CGH array.